Systemic antispasticity drugs vs placebo
Adverse events Adverse events per participant · people with spasticity following stroke
It is very uncertain whether systemic antispasticity drugs changes adverse events Adverse events per participant compared with placebo (very low certainty).
1 finding from 1 review
- Pharmacological interventions other than botulinum toxin for spasticity after stroke 2016 · Cochrane Headline outcomes onlyRR 1.65 [1.12, 2.42]2 studies · 160 participantsVery low